Showing results 5 to 6 of 6
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Surprisingly Promising Tumor Control Rate of S1 Combination with Anlotinib with Refractory Relapsed SCLC Who Failed ≥ 2 Lines Chemotherapy Proceeding/Conference:Journal of Thoracic Oncology | 2019 | ||
Update Phase II Results of Early Primary Tumor Stereotactic Body Radiotherapy Combined with First-Line EGFR-TKI in Advanced EGFR Mutated NSCLC Proceeding/Conference:Journal of Thoracic Oncology | 2019 |